

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.58620491 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.58620491 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 4.58620491 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 4.58620491 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 4.58620491 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.58620491 |
| 7 | glucose 6-phosphate metabolic process (GO:0051156) | 4.46211821 |
| 8 | response to peptidoglycan (GO:0032494) | 4.42569145 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 4.38815141 |
| 10 | low-density lipoprotein particle clearance (GO:0034383) | 4.18737981 |
| 11 | respiratory burst (GO:0045730) | 3.99251652 |
| 12 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.79972440 |
| 13 | glycosphingolipid catabolic process (GO:0046479) | 3.78420449 |
| 14 | leukocyte aggregation (GO:0070486) | 3.68497798 |
| 15 | response to fungus (GO:0009620) | 3.63118981 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 3.62976540 |
| 17 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.57019969 |
| 18 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.55428499 |
| 19 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.53907768 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 3.49749458 |
| 21 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.42038244 |
| 22 | macrophage activation involved in immune response (GO:0002281) | 3.37890499 |
| 23 | neutrophil mediated immunity (GO:0002446) | 3.37608294 |
| 24 | regulation of superoxide anion generation (GO:0032928) | 3.35932960 |
| 25 | glycolipid catabolic process (GO:0019377) | 3.32727554 |
| 26 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.32651603 |
| 27 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.32593386 |
| 28 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.32593386 |
| 29 | reactive oxygen species biosynthetic process (GO:1903409) | 3.28346432 |
| 30 | Golgi transport vesicle coating (GO:0048200) | 3.27987338 |
| 31 | COPI coating of Golgi vesicle (GO:0048205) | 3.27987338 |
| 32 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.25561638 |
| 33 | response to host immune response (GO:0052572) | 3.25561638 |
| 34 | defense response to fungus (GO:0050832) | 3.22770883 |
| 35 | barbed-end actin filament capping (GO:0051016) | 3.19184363 |
| 36 | neutrophil activation (GO:0042119) | 3.18515546 |
| 37 | negative regulation of interleukin-12 production (GO:0032695) | 3.17482051 |
| 38 | granulocyte activation (GO:0036230) | 3.17141332 |
| 39 | positive regulation of interferon-alpha production (GO:0032727) | 3.16537356 |
| 40 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.13775157 |
| 41 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.13420398 |
| 42 | daunorubicin metabolic process (GO:0044597) | 3.11239578 |
| 43 | polyketide metabolic process (GO:0030638) | 3.11239578 |
| 44 | doxorubicin metabolic process (GO:0044598) | 3.11239578 |
| 45 | * pentose-phosphate shunt (GO:0006098) | 3.10184936 |
| 46 | negative regulation of phagocytosis (GO:0050765) | 3.07866960 |
| 47 | amino sugar catabolic process (GO:0046348) | 3.06716637 |
| 48 | protein localization to endosome (GO:0036010) | 3.06161434 |
| 49 | detection of other organism (GO:0098543) | 3.05404428 |
| 50 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.05399815 |
| 51 | regulation of cholesterol storage (GO:0010885) | 3.01660344 |
| 52 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.01329705 |
| 53 | cellular extravasation (GO:0045123) | 3.00973844 |
| 54 | B cell mediated immunity (GO:0019724) | 3.00092024 |
| 55 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.99124098 |
| 56 | response to host (GO:0075136) | 2.99124098 |
| 57 | response to host defenses (GO:0052200) | 2.99124098 |
| 58 | regulation of interferon-alpha production (GO:0032647) | 2.98064826 |
| 59 | leukocyte mediated cytotoxicity (GO:0001909) | 2.96839961 |
| 60 | oligosaccharide catabolic process (GO:0009313) | 2.96755991 |
| 61 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.94833920 |
| 62 | natural killer cell mediated immunity (GO:0002228) | 2.94678553 |
| 63 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.94678553 |
| 64 | * NADPH regeneration (GO:0006740) | 2.89196363 |
| 65 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.89167815 |
| 66 | ceramide catabolic process (GO:0046514) | 2.82755140 |
| 67 | superoxide anion generation (GO:0042554) | 2.80662264 |
| 68 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.80055163 |
| 69 | leukotriene metabolic process (GO:0006691) | 2.79180802 |
| 70 | response to muramyl dipeptide (GO:0032495) | 2.76209022 |
| 71 | response to thyroid hormone (GO:0097066) | 2.75550601 |
| 72 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.75370620 |
| 73 | pinocytosis (GO:0006907) | 2.73864012 |
| 74 | detection of external biotic stimulus (GO:0098581) | 2.73100897 |
| 75 | nuclear pore complex assembly (GO:0051292) | 2.72457238 |
| 76 | detection of bacterium (GO:0016045) | 2.72441394 |
| 77 | DNA unwinding involved in DNA replication (GO:0006268) | 2.71248976 |
| 78 | * pentose metabolic process (GO:0019321) | 2.69948732 |
| 79 | regulation of early endosome to late endosome transport (GO:2000641) | 2.66271540 |
| 80 | T cell apoptotic process (GO:0070231) | 2.65599028 |
| 81 | stress fiber assembly (GO:0043149) | 2.63146012 |
| 82 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.62825392 |
| 83 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.62523442 |
| 84 | regulation of mast cell degranulation (GO:0043304) | 2.61854338 |
| 85 | regulation of leukocyte degranulation (GO:0043300) | 2.61745427 |
| 86 | glycoside metabolic process (GO:0016137) | 2.60526897 |
| 87 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.59771304 |
| 88 | modulation by symbiont of host cellular process (GO:0044068) | 2.59286738 |
| 89 | apoptotic cell clearance (GO:0043277) | 2.58673632 |
| 90 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.58523536 |
| 91 | actin nucleation (GO:0045010) | 2.58101123 |
| 92 | macrophage differentiation (GO:0030225) | 2.56431432 |
| 93 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.55545643 |
| 94 | sequestering of metal ion (GO:0051238) | 2.53524624 |
| 95 | regulation of podosome assembly (GO:0071801) | 2.53411136 |
| 96 | regulation of protein heterodimerization activity (GO:0043497) | 2.53198188 |
| 97 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.51991356 |
| 98 | myeloid cell homeostasis (GO:0002262) | 2.51631783 |
| 99 | regulation of chemokine biosynthetic process (GO:0045073) | 2.51441352 |
| 100 | detection of biotic stimulus (GO:0009595) | 2.51438496 |
| 101 | positive regulation of interferon-beta production (GO:0032728) | 2.51262427 |
| 102 | establishment of integrated proviral latency (GO:0075713) | 2.50611301 |
| 103 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.50000610 |
| 104 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.49224182 |
| 105 | leukocyte cell-cell adhesion (GO:0007159) | 2.48800288 |
| 106 | formation of translation preinitiation complex (GO:0001731) | 2.47598456 |
| 107 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.47503872 |
| 108 | regulation of regulated secretory pathway (GO:1903305) | 2.46697237 |
| 109 | cellular response to zinc ion (GO:0071294) | 2.44488757 |
| 110 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.44334866 |
| 111 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.43487540 |
| 112 | regulation of growth of symbiont in host (GO:0044126) | 2.43487540 |
| 113 | negative regulation of growth of symbiont in host (GO:0044130) | 2.43487540 |
| 114 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.43487540 |
| 115 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.43243293 |
| 116 | positive regulation of mast cell activation (GO:0033005) | 2.43223867 |
| 117 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.41777291 |
| 118 | regulation of integrin activation (GO:0033623) | 2.41773695 |
| 119 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.41596044 |
| 120 | regulation of mast cell activation (GO:0033003) | 2.40616738 |
| 121 | myeloid cell activation involved in immune response (GO:0002275) | 2.40481255 |
| 122 | myeloid leukocyte mediated immunity (GO:0002444) | 2.39242953 |
| 123 | positive regulation of leukocyte degranulation (GO:0043302) | 2.38658070 |
| 124 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.38288251 |
| 125 | modulation by virus of host process (GO:0019054) | 2.37850717 |
| 126 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.37045316 |
| 127 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.37045316 |
| 128 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.36516868 |
| 129 | mRNA stabilization (GO:0048255) | 2.35226488 |
| 130 | RNA stabilization (GO:0043489) | 2.35226488 |
| 131 | positive regulation of antigen processing and presentation (GO:0002579) | 2.34091632 |
| 132 | IMP biosynthetic process (GO:0006188) | 2.34007558 |
| 133 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.33859596 |
| 134 | membrane lipid catabolic process (GO:0046466) | 2.33456833 |
| 135 | N-acetylneuraminate metabolic process (GO:0006054) | 2.32510004 |
| 136 | response to laminar fluid shear stress (GO:0034616) | 2.32229023 |
| 137 | * NADP metabolic process (GO:0006739) | 2.32029747 |
| 138 | detection of molecule of bacterial origin (GO:0032490) | 2.31744630 |
| 139 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.30686514 |
| 140 | mannose metabolic process (GO:0006013) | 2.29169458 |
| 141 | establishment of viral latency (GO:0019043) | 2.28823716 |
| 142 | sphingolipid catabolic process (GO:0030149) | 2.27963218 |
| 143 | mitotic chromosome condensation (GO:0007076) | 2.26964665 |
| 144 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.26222503 |
| 145 | regulation of mononuclear cell migration (GO:0071675) | 2.26159824 |
| 146 | lymphocyte apoptotic process (GO:0070227) | 2.25471126 |
| 147 | * glucose catabolic process (GO:0006007) | 2.25424978 |
| 148 | tricarboxylic acid metabolic process (GO:0072350) | 2.25257420 |
| 149 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.24367107 |
| 150 | positive regulation of B cell differentiation (GO:0045579) | 2.24107371 |
| 151 | chronic inflammatory response (GO:0002544) | 2.23884853 |
| 152 | neutrophil chemotaxis (GO:0030593) | 2.23821697 |
| 153 | cytokine secretion (GO:0050663) | 2.19361210 |
| 154 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.18501870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.84160849 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.43368176 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.30511129 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.71350047 |
| 5 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.71225358 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.62909586 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.61537771 |
| 8 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.60857545 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.50635745 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.40594527 |
| 11 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.40326010 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.33822402 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.32258638 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.30704961 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.25627071 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.25115674 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.15359897 |
| 18 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.05235662 |
| 19 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.00848347 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 1.96394682 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.89817848 |
| 22 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.89580580 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.81938701 |
| 24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.74958240 |
| 25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.72788324 |
| 26 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.70739709 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.70042408 |
| 28 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.66827773 |
| 29 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.66102475 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.65614469 |
| 31 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.65311077 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.56219688 |
| 33 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.52687822 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51856717 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50376424 |
| 36 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.49129672 |
| 37 | * MAF_26560356_Chip-Seq_TH1_Human | 1.48066149 |
| 38 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.46520029 |
| 39 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.46490883 |
| 40 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.42574476 |
| 41 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.41987277 |
| 42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.39042293 |
| 43 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.38620809 |
| 44 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.36324542 |
| 45 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.35255471 |
| 46 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.32713661 |
| 47 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.32451926 |
| 48 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.31966454 |
| 49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31268238 |
| 50 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.29827896 |
| 51 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.29782455 |
| 52 | MYB_26560356_Chip-Seq_TH2_Human | 1.29780143 |
| 53 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.29605071 |
| 54 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.29499239 |
| 55 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.27862687 |
| 56 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.27720280 |
| 57 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27305012 |
| 58 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26515906 |
| 59 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.25960647 |
| 60 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.25776914 |
| 61 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.25737643 |
| 62 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.23436167 |
| 63 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22450262 |
| 64 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.22314815 |
| 65 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.21658671 |
| 66 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.19768080 |
| 67 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19045070 |
| 68 | MYB_26560356_Chip-Seq_TH1_Human | 1.18474898 |
| 69 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.17168081 |
| 70 | SPI1_23127762_ChIP-Seq_K562_Human | 1.16776322 |
| 71 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.16471497 |
| 72 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16319622 |
| 73 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.16045067 |
| 74 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15938675 |
| 75 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15926549 |
| 76 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15729662 |
| 77 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.13961660 |
| 78 | ATF3_27146783_Chip-Seq_COLON_Human | 1.11023200 |
| 79 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.10964607 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09002809 |
| 81 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.08794640 |
| 82 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.08695377 |
| 83 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.08539134 |
| 84 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.08408950 |
| 85 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.08036107 |
| 86 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.07572460 |
| 87 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.07188372 |
| 88 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.07074312 |
| 89 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.06919539 |
| 90 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.05765136 |
| 91 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.05727336 |
| 92 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.05558642 |
| 93 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.05286947 |
| 94 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.05240025 |
| 95 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.04333710 |
| 96 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.04313532 |
| 97 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.04171330 |
| 98 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.03805612 |
| 99 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.03599442 |
| 100 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.03446242 |
| 101 | MAF_26560356_Chip-Seq_TH2_Human | 1.03312399 |
| 102 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.03240530 |
| 103 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.03085093 |
| 104 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.02495249 |
| 105 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.02056560 |
| 106 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01518363 |
| 107 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.99553257 |
| 108 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.98311353 |
| 109 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97934216 |
| 110 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.97865191 |
| 111 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96499420 |
| 112 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.96463150 |
| 113 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96389326 |
| 114 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95606984 |
| 115 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.94093146 |
| 116 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.93799857 |
| 117 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.90822349 |
| 118 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.90755597 |
| 119 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90642613 |
| 120 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.90577761 |
| 121 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.89514704 |
| 122 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.88891674 |
| 123 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.88218549 |
| 124 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.87156542 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.31235583 |
| 2 | MP0003436_decreased_susceptibility_to | 3.31162466 |
| 3 | MP0005058_abnormal_lysosome_morphology | 2.99499704 |
| 4 | MP0005451_abnormal_body_composition | 2.59629849 |
| 5 | MP0009785_altered_susceptibility_to | 2.47497448 |
| 6 | MP0002419_abnormal_innate_immunity | 2.42830427 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.39796026 |
| 8 | MP0009278_abnormal_bone_marrow | 2.21314871 |
| 9 | MP0009840_abnormal_foam_cell | 2.18097226 |
| 10 | MP0010352_gastrointestinal_tract_polyps | 2.17841666 |
| 11 | MP0003705_abnormal_hypodermis_morpholog | 2.15316152 |
| 12 | MP0005025_abnormal_response_to | 2.08198515 |
| 13 | MP0003566_abnormal_cell_adhesion | 2.01491125 |
| 14 | MP0002877_abnormal_melanocyte_morpholog | 1.94822979 |
| 15 | MP0005000_abnormal_immune_tolerance | 1.91479373 |
| 16 | MP0003172_abnormal_lysosome_physiology | 1.89977440 |
| 17 | MP0003693_abnormal_embryo_hatching | 1.89551207 |
| 18 | MP0005464_abnormal_platelet_physiology | 1.87106014 |
| 19 | MP0001533_abnormal_skeleton_physiology | 1.87008255 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 1.86999701 |
| 21 | MP0002452_abnormal_antigen_presenting | 1.81268153 |
| 22 | MP0005076_abnormal_cell_differentiation | 1.78822224 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 1.76669963 |
| 24 | MP0002139_abnormal_hepatobiliary_system | 1.75991910 |
| 25 | MP0000858_altered_metastatic_potential | 1.75855181 |
| 26 | MP0006082_CNS_inflammation | 1.74409203 |
| 27 | MP0010307_abnormal_tumor_latency | 1.73694065 |
| 28 | MP0003724_increased_susceptibility_to | 1.72233597 |
| 29 | MP0003300_gastrointestinal_ulcer | 1.71646883 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 1.69269531 |
| 31 | MP0000343_altered_response_to | 1.66709896 |
| 32 | MP0003448_altered_tumor_morphology | 1.66205483 |
| 33 | MP0002405_respiratory_system_inflammati | 1.63751606 |
| 34 | MP0005397_hematopoietic_system_phenotyp | 1.63167787 |
| 35 | MP0001545_abnormal_hematopoietic_system | 1.63167787 |
| 36 | MP0000685_abnormal_immune_system | 1.62202753 |
| 37 | MP0008438_abnormal_cutaneous_collagen | 1.60866127 |
| 38 | MP0004947_skin_inflammation | 1.59384291 |
| 39 | MP0000604_amyloidosis | 1.59325391 |
| 40 | MP0009333_abnormal_splenocyte_physiolog | 1.58289729 |
| 41 | MP0001819_abnormal_immune_cell | 1.57263400 |
| 42 | MP0002420_abnormal_adaptive_immunity | 1.55280595 |
| 43 | MP0001800_abnormal_humoral_immune | 1.54727635 |
| 44 | MP0005387_immune_system_phenotype | 1.53395174 |
| 45 | MP0001790_abnormal_immune_system | 1.53395174 |
| 46 | MP0002723_abnormal_immune_serum | 1.52032470 |
| 47 | MP0000490_abnormal_crypts_of | 1.48208379 |
| 48 | MP0001853_heart_inflammation | 1.46789639 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.45734109 |
| 50 | MP0005023_abnormal_wound_healing | 1.43605342 |
| 51 | MP0002396_abnormal_hematopoietic_system | 1.40098400 |
| 52 | MP0010155_abnormal_intestine_physiology | 1.39854071 |
| 53 | MP0003186_abnormal_redox_activity | 1.34367258 |
| 54 | MP0002254_reproductive_system_inflammat | 1.26609533 |
| 55 | MP0008007_abnormal_cellular_replicative | 1.23224920 |
| 56 | MP0001958_emphysema | 1.23020657 |
| 57 | MP0003111_abnormal_nucleus_morphology | 1.21452214 |
| 58 | MP0004233_abnormal_muscle_weight | 1.21125291 |
| 59 | MP0002398_abnormal_bone_marrow | 1.20105423 |
| 60 | MP0008469_abnormal_protein_level | 1.19872705 |
| 61 | MP0000716_abnormal_immune_system | 1.19814718 |
| 62 | MP0001915_intracranial_hemorrhage | 1.19351137 |
| 63 | MP0004808_abnormal_hematopoietic_stem | 1.18882108 |
| 64 | MP0003183_abnormal_peptide_metabolism | 1.17390502 |
| 65 | MP0004957_abnormal_blastocyst_morpholog | 1.16247767 |
| 66 | MP0004185_abnormal_adipocyte_glucose | 1.15539442 |
| 67 | MP0002132_abnormal_respiratory_system | 1.14271914 |
| 68 | MP0000689_abnormal_spleen_morphology | 1.13754815 |
| 69 | MP0002429_abnormal_blood_cell | 1.11010279 |
| 70 | MP0002722_abnormal_immune_system | 1.10466533 |
| 71 | MP0008932_abnormal_embryonic_tissue | 1.07356558 |
| 72 | MP0000465_gastrointestinal_hemorrhage | 1.06382706 |
| 73 | MP0003077_abnormal_cell_cycle | 1.05234315 |
| 74 | MP0003329_amyloid_beta_deposits | 1.04339316 |
| 75 | MP0000313_abnormal_cell_death | 1.03202925 |
| 76 | MP0005671_abnormal_response_to | 1.02648060 |
| 77 | MP0003075_altered_response_to | 1.02411692 |
| 78 | MP0009672_abnormal_birth_weight | 1.01959901 |
| 79 | MP0003828_pulmonary_edema | 1.01100251 |
| 80 | MP0010094_abnormal_chromosome_stability | 0.98780206 |
| 81 | MP0009764_decreased_sensitivity_to | 0.98681277 |
| 82 | MP0005390_skeleton_phenotype | 0.98017171 |
| 83 | MP0005257_abnormal_intraocular_pressure | 0.96983351 |
| 84 | MP0004883_abnormal_blood_vessel | 0.94441652 |
| 85 | MP0002006_tumorigenesis | 0.93537515 |
| 86 | MP0003453_abnormal_keratinocyte_physiol | 0.92252380 |
| 87 | MP0000569_abnormal_digit_pigmentation | 0.91916455 |
| 88 | MP0002998_abnormal_bone_remodeling | 0.91789776 |
| 89 | MP0001873_stomach_inflammation | 0.91302396 |
| 90 | MP0004858_abnormal_nervous_system | 0.90952250 |
| 91 | MP0002019_abnormal_tumor_incidence | 0.90869877 |
| 92 | MP0002166_altered_tumor_susceptibility | 0.88460426 |
| 93 | MP0002796_impaired_skin_barrier | 0.88218595 |
| 94 | MP0002080_prenatal_lethality | 0.87925721 |
| 95 | MP0006054_spinal_hemorrhage | 0.87873059 |
| 96 | MP0001851_eye_inflammation | 0.87681595 |
| 97 | MP0003690_abnormal_glial_cell | 0.87589851 |
| 98 | MP0000358_abnormal_cell_content/ | 0.87525065 |
| 99 | MP0001730_embryonic_growth_arrest | 0.87225088 |
| 100 | MP0005621_abnormal_cell_physiology | 0.86836164 |
| 101 | MP0001881_abnormal_mammary_gland | 0.86769934 |
| 102 | MP0005164_abnormal_response_to | 0.86398552 |
| 103 | MP0003806_abnormal_nucleotide_metabolis | 0.85845473 |
| 104 | MP0002933_joint_inflammation | 0.85620795 |
| 105 | MP0005666_abnormal_adipose_tissue | 0.84716315 |
| 106 | MP0005310_abnormal_salivary_gland | 0.84518522 |
| 107 | MP0005167_abnormal_blood-brain_barrier | 0.84417620 |
| 108 | MP0000350_abnormal_cell_proliferation | 0.82888854 |
| 109 | MP0005248_abnormal_Harderian_gland | 0.82874160 |
| 110 | MP0004510_myositis | 0.82648445 |
| 111 | MP0001727_abnormal_embryo_implantation | 0.81581540 |
| 112 | MP0001849_ear_inflammation | 0.81431923 |
| 113 | MP0005670_abnormal_white_adipose | 0.80850700 |
| 114 | MP0005083_abnormal_biliary_tract | 0.80614118 |
| 115 | MP0004782_abnormal_surfactant_physiolog | 0.79800293 |
| 116 | MP0003091_abnormal_cell_migration | 0.79327196 |
| 117 | MP0009115_abnormal_fat_cell | 0.77148885 |
| 118 | MP0005174_abnormal_tail_pigmentation | 0.75362119 |
| 119 | MP0000249_abnormal_blood_vessel | 0.74648889 |
| 120 | MP0005166_decreased_susceptibility_to | 0.74108728 |
| 121 | MP0010234_abnormal_vibrissa_follicle | 0.74041388 |
| 122 | MP0000371_diluted_coat_color | 0.73759194 |
| 123 | MP0008260_abnormal_autophagy | 0.72351697 |
| 124 | MP0000609_abnormal_liver_physiology | 0.71814079 |
| 125 | MP0009763_increased_sensitivity_to | 0.71373416 |
| 126 | MP0003221_abnormal_cardiomyocyte_apopto | 0.71177503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.23824801 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.09761071 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.23162435 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.94153135 |
| 5 | Abnormality of macrophages (HP:0004311) | 4.55996548 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 4.23554624 |
| 7 | Abnormal gallbladder physiology (HP:0012438) | 3.77959232 |
| 8 | Cholecystitis (HP:0001082) | 3.77959232 |
| 9 | Increased cerebral lipofuscin (HP:0011813) | 3.66429603 |
| 10 | Chronic obstructive pulmonary disease (HP:0006510) | 3.61390933 |
| 11 | Obstructive lung disease (HP:0006536) | 3.61390933 |
| 12 | Autoimmune thrombocytopenia (HP:0001973) | 3.56046845 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 3.48739752 |
| 14 | Gingivitis (HP:0000230) | 3.43873091 |
| 15 | Pustule (HP:0200039) | 3.15709621 |
| 16 | Interstitial pulmonary disease (HP:0006530) | 3.14786436 |
| 17 | Cortical dysplasia (HP:0002539) | 3.14196666 |
| 18 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.11676315 |
| 19 | Axonal loss (HP:0003447) | 3.09058005 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.07598265 |
| 21 | Recurrent fungal infections (HP:0002841) | 3.06310249 |
| 22 | Dysostosis multiplex (HP:0000943) | 3.01266215 |
| 23 | Myositis (HP:0100614) | 2.99932229 |
| 24 | Recurrent skin infections (HP:0001581) | 2.96158445 |
| 25 | Cellulitis (HP:0100658) | 2.88406958 |
| 26 | Urticaria (HP:0001025) | 2.71636905 |
| 27 | Osteolytic defects of the hand bones (HP:0009699) | 2.70779101 |
| 28 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.70779101 |
| 29 | Systemic lupus erythematosus (HP:0002725) | 2.69261976 |
| 30 | Periodontitis (HP:0000704) | 2.68300658 |
| 31 | Mucopolysacchariduria (HP:0008155) | 2.63589544 |
| 32 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.63589544 |
| 33 | Abnormality of glycolipid metabolism (HP:0010969) | 2.57362672 |
| 34 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.57362672 |
| 35 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.57362672 |
| 36 | Orchitis (HP:0100796) | 2.54690993 |
| 37 | Cervical subluxation (HP:0003308) | 2.53359904 |
| 38 | Disinhibition (HP:0000734) | 2.52801352 |
| 39 | Amyloidosis (HP:0011034) | 2.46937554 |
| 40 | Purpura (HP:0000979) | 2.40134238 |
| 41 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.40083367 |
| 42 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.40083367 |
| 43 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.40083367 |
| 44 | Recurrent viral infections (HP:0004429) | 2.36389852 |
| 45 | Petechiae (HP:0000967) | 2.35677745 |
| 46 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.34076448 |
| 47 | Agnosia (HP:0010524) | 2.33901262 |
| 48 | Osteomyelitis (HP:0002754) | 2.32823260 |
| 49 | Chronic otitis media (HP:0000389) | 2.30087488 |
| 50 | Nausea (HP:0002018) | 2.28337555 |
| 51 | Reticulocytosis (HP:0001923) | 2.26992214 |
| 52 | Peritonitis (HP:0002586) | 2.25618220 |
| 53 | Multiple enchondromatosis (HP:0005701) | 2.25396924 |
| 54 | Stomatitis (HP:0010280) | 2.24295904 |
| 55 | Myocardial infarction (HP:0001658) | 2.24271828 |
| 56 | Apathy (HP:0000741) | 2.24123398 |
| 57 | Polycythemia (HP:0001901) | 2.22423021 |
| 58 | Hepatosplenomegaly (HP:0001433) | 2.21677183 |
| 59 | Nuclear cataract (HP:0100018) | 2.19071019 |
| 60 | Cholelithiasis (HP:0001081) | 2.17893982 |
| 61 | Spastic diplegia (HP:0001264) | 2.17046498 |
| 62 | Leukocytosis (HP:0001974) | 2.12145113 |
| 63 | Thrombocytosis (HP:0001894) | 2.03876843 |
| 64 | Skin ulcer (HP:0200042) | 2.02519050 |
| 65 | Prolonged bleeding time (HP:0003010) | 1.99541412 |
| 66 | Amaurosis fugax (HP:0100576) | 1.98051693 |
| 67 | Loss of speech (HP:0002371) | 1.96847808 |
| 68 | Orthostatic hypotension (HP:0001278) | 1.95963095 |
| 69 | Vasculitis (HP:0002633) | 1.95755728 |
| 70 | Hematochezia (HP:0002573) | 1.93351027 |
| 71 | Progressive neurologic deterioration (HP:0002344) | 1.92984767 |
| 72 | Vertebral compression fractures (HP:0002953) | 1.92879332 |
| 73 | Poor head control (HP:0002421) | 1.92805765 |
| 74 | Tetraparesis (HP:0002273) | 1.91341657 |
| 75 | Cerebral aneurysm (HP:0004944) | 1.90884869 |
| 76 | Meningitis (HP:0001287) | 1.90878389 |
| 77 | Basal ganglia calcification (HP:0002135) | 1.90320656 |
| 78 | Thoracic kyphosis (HP:0002942) | 1.89610812 |
| 79 | Mutism (HP:0002300) | 1.89122900 |
| 80 | Metaphyseal cupping (HP:0003021) | 1.89057741 |
| 81 | Abnormal gallbladder morphology (HP:0012437) | 1.87543281 |
| 82 | Hypertensive crisis (HP:0100735) | 1.86036147 |
| 83 | Neuronal loss in central nervous system (HP:0002529) | 1.85692484 |
| 84 | Increased serum ferritin (HP:0003281) | 1.85479996 |
| 85 | Rough bone trabeculation (HP:0100670) | 1.85373493 |
| 86 | Cheilitis (HP:0100825) | 1.85205409 |
| 87 | Increased mean platelet volume (HP:0011877) | 1.84186977 |
| 88 | IgM deficiency (HP:0002850) | 1.84180109 |
| 89 | Spontaneous hematomas (HP:0007420) | 1.83046936 |
| 90 | Hyperacusis (HP:0010780) | 1.82968977 |
| 91 | Hand muscle atrophy (HP:0009130) | 1.80931352 |
| 92 | Ulnar bowing (HP:0003031) | 1.80483925 |
| 93 | Pathologic fracture (HP:0002756) | 1.80420157 |
| 94 | Eosinophilia (HP:0001880) | 1.79480190 |
| 95 | Epistaxis (HP:0000421) | 1.79319207 |
| 96 | Cerebral inclusion bodies (HP:0100314) | 1.78398646 |
| 97 | Abnormality of the gallbladder (HP:0005264) | 1.76980849 |
| 98 | Premature rupture of membranes (HP:0001788) | 1.76621987 |
| 99 | Progressive external ophthalmoplegia (HP:0000590) | 1.75906281 |
| 100 | Polygenic inheritance (HP:0010982) | 1.75826797 |
| 101 | Abnormality of reticulocytes (HP:0004312) | 1.75432053 |
| 102 | Granulocytopenia (HP:0001913) | 1.75109625 |
| 103 | Increased density of long bones (HP:0006392) | 1.74519186 |
| 104 | Abnormal platelet volume (HP:0011876) | 1.73566657 |
| 105 | Disproportionate tall stature (HP:0001519) | 1.73361442 |
| 106 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.72568681 |
| 107 | Premature loss of primary teeth (HP:0006323) | 1.72506403 |
| 108 | Ankle contracture (HP:0006466) | 1.72292797 |
| 109 | Impaired platelet aggregation (HP:0003540) | 1.71367851 |
| 110 | Gingival bleeding (HP:0000225) | 1.70984641 |
| 111 | Personality changes (HP:0000751) | 1.70248882 |
| 112 | Nasal polyposis (HP:0100582) | 1.69617545 |
| 113 | Neurofibrillary tangles (HP:0002185) | 1.68882149 |
| 114 | Abnormality of the thoracic spine (HP:0100711) | 1.68600252 |
| 115 | Abnormality of the lumbar spine (HP:0100712) | 1.68547916 |
| 116 | Upper motor neuron abnormality (HP:0002127) | 1.67782473 |
| 117 | Hypertriglyceridemia (HP:0002155) | 1.66741628 |
| 118 | Pulmonary infiltrates (HP:0002113) | 1.66467812 |
| 119 | Recurrent pneumonia (HP:0006532) | 1.66091805 |
| 120 | Abnormal trabecular bone morphology (HP:0100671) | 1.66069231 |
| 121 | Abnormality of the nasal mucosa (HP:0000433) | 1.65661222 |
| 122 | Prolonged neonatal jaundice (HP:0006579) | 1.64755191 |
| 123 | Diminished motivation (HP:0000745) | 1.64582439 |
| 124 | Uterine leiomyosarcoma (HP:0002891) | 1.64038326 |
| 125 | Leiomyosarcoma (HP:0100243) | 1.64038326 |
| 126 | Recurrent lower respiratory tract infections (HP:0002783) | 1.63587062 |
| 127 | Increased IgE level (HP:0003212) | 1.63391047 |
| 128 | Elevated alkaline phosphatase (HP:0003155) | 1.62690308 |
| 129 | Chest pain (HP:0100749) | 1.62204534 |
| 130 | Abnormality of glycolysis (HP:0004366) | 1.62094994 |
| 131 | Abnormality of T cell physiology (HP:0011840) | 1.61739868 |
| 132 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.61298235 |
| 133 | Recurrent cutaneous fungal infections (HP:0011370) | 1.61298235 |
| 134 | Long palpebral fissure (HP:0000637) | 1.61257004 |
| 135 | Peripheral demyelination (HP:0011096) | 1.61027794 |
| 136 | Neoplasm of head and neck (HP:0012288) | 1.60515411 |
| 137 | Esophageal neoplasm (HP:0100751) | 1.60515411 |
| 138 | Bone pain (HP:0002653) | 1.60351047 |
| 139 | Ragged-red muscle fibers (HP:0003200) | 1.59667458 |
| 140 | Arterial thrombosis (HP:0004420) | 1.59119625 |
| 141 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.59035530 |
| 142 | Nephritis (HP:0000123) | 1.58554966 |
| 143 | Abnormality of iron homeostasis (HP:0011031) | 1.57993265 |
| 144 | Abnormal platelet function (HP:0011869) | 1.57431483 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.51529363 |
| 2 | ERN1 | 3.30666648 |
| 3 | SMG1 | 3.05104035 |
| 4 | BLK | 2.76605231 |
| 5 | PKN2 | 2.52963145 |
| 6 | PRPF4B | 2.38798188 |
| 7 | IRAK4 | 2.33717640 |
| 8 | STK10 | 2.17820755 |
| 9 | IRAK3 | 2.04241307 |
| 10 | MAP4K1 | 2.00412986 |
| 11 | TBK1 | 1.88439555 |
| 12 | PIM2 | 1.81826388 |
| 13 | PAK4 | 1.81288506 |
| 14 | LRRK2 | 1.79508108 |
| 15 | TESK2 | 1.76952612 |
| 16 | TAOK2 | 1.75709782 |
| 17 | EEF2K | 1.74202563 |
| 18 | NME2 | 1.69739069 |
| 19 | TESK1 | 1.62778171 |
| 20 | TYK2 | 1.62194184 |
| 21 | RIPK4 | 1.60335367 |
| 22 | EPHB1 | 1.59927685 |
| 23 | ICK | 1.55114868 |
| 24 | RPS6KA4 | 1.54809517 |
| 25 | ZAP70 | 1.52817560 |
| 26 | EPHA2 | 1.46066457 |
| 27 | PTK6 | 1.44729243 |
| 28 | TTN | 1.44701922 |
| 29 | MAP2K3 | 1.43542126 |
| 30 | MST1R | 1.40562752 |
| 31 | CSK | 1.36890387 |
| 32 | KIT | 1.36355137 |
| 33 | CAMK1D | 1.35456077 |
| 34 | BUB1 | 1.35374056 |
| 35 | NEK2 | 1.35341046 |
| 36 | BMX | 1.33034866 |
| 37 | MAP3K11 | 1.32150107 |
| 38 | SRPK1 | 1.28793625 |
| 39 | MAP3K8 | 1.28192257 |
| 40 | MAP3K14 | 1.27200373 |
| 41 | WEE1 | 1.26335651 |
| 42 | BTK | 1.26137842 |
| 43 | CDK12 | 1.24357181 |
| 44 | JAK3 | 1.24137997 |
| 45 | RIPK1 | 1.22004989 |
| 46 | GRK6 | 1.11913213 |
| 47 | CSF1R | 1.09415457 |
| 48 | TRPM7 | 1.05614615 |
| 49 | FGFR4 | 1.04109090 |
| 50 | MAP3K10 | 1.03713443 |
| 51 | DYRK3 | 1.02614080 |
| 52 | PIM1 | 1.02009828 |
| 53 | IRAK2 | 0.99952938 |
| 54 | VRK2 | 0.99709133 |
| 55 | MATK | 0.98203836 |
| 56 | DDR2 | 0.97939242 |
| 57 | YES1 | 0.96388251 |
| 58 | ALK | 0.95800842 |
| 59 | CDK6 | 0.94629876 |
| 60 | MAP3K3 | 0.93319523 |
| 61 | IKBKB | 0.93054635 |
| 62 | HCK | 0.92754833 |
| 63 | CDK4 | 0.90578878 |
| 64 | TAOK3 | 0.89851136 |
| 65 | FLT3 | 0.89203711 |
| 66 | PBK | 0.88622986 |
| 67 | KDR | 0.88367726 |
| 68 | SIK3 | 0.87556732 |
| 69 | MAP3K1 | 0.86994678 |
| 70 | KSR1 | 0.84421894 |
| 71 | FGR | 0.83218577 |
| 72 | CDK7 | 0.82867047 |
| 73 | TEC | 0.81676341 |
| 74 | MAP3K6 | 0.80210158 |
| 75 | TGFBR2 | 0.79491549 |
| 76 | ARAF | 0.78908161 |
| 77 | SIK1 | 0.78378829 |
| 78 | TSSK6 | 0.78184561 |
| 79 | PRKG2 | 0.77741593 |
| 80 | MAP2K2 | 0.75599968 |
| 81 | PDK2 | 0.74721704 |
| 82 | IKBKE | 0.74662048 |
| 83 | STK3 | 0.74469911 |
| 84 | NEK9 | 0.71984399 |
| 85 | ERBB4 | 0.71942018 |
| 86 | RPS6KB2 | 0.71850612 |
| 87 | SCYL2 | 0.71468242 |
| 88 | LATS2 | 0.71419921 |
| 89 | MOS | 0.71306891 |
| 90 | EIF2AK1 | 0.69912461 |
| 91 | STK4 | 0.69635573 |
| 92 | ABL2 | 0.69093332 |
| 93 | MAP3K13 | 0.68104030 |
| 94 | JAK1 | 0.66091782 |
| 95 | PDGFRA | 0.65673185 |
| 96 | CDC42BPA | 0.64754730 |
| 97 | PAK1 | 0.64560160 |
| 98 | LYN | 0.64552866 |
| 99 | SYK | 0.63135585 |
| 100 | MST4 | 0.62997360 |
| 101 | KSR2 | 0.62766392 |
| 102 | JAK2 | 0.62316552 |
| 103 | FES | 0.59648265 |
| 104 | LCK | 0.59110661 |
| 105 | PTK2 | 0.57413752 |
| 106 | CHUK | 0.56679122 |
| 107 | MKNK1 | 0.56551771 |
| 108 | CDC7 | 0.55219626 |
| 109 | ILK | 0.53691177 |
| 110 | CAMK1G | 0.53629613 |
| 111 | RAF1 | 0.52103074 |
| 112 | PDPK1 | 0.51268722 |
| 113 | CLK1 | 0.50837725 |
| 114 | TTK | 0.50486640 |
| 115 | MAP3K5 | 0.50451026 |
| 116 | EGFR | 0.48654968 |
| 117 | MAPKAPK2 | 0.48619879 |
| 118 | CDK9 | 0.48295935 |
| 119 | GRK7 | 0.48230016 |
| 120 | MET | 0.48205294 |
| 121 | BRSK2 | 0.47085994 |
| 122 | NEK1 | 0.46761034 |
| 123 | MTOR | 0.45743038 |
| 124 | TAOK1 | 0.44965085 |
| 125 | BRAF | 0.44914821 |
| 126 | MARK3 | 0.44588968 |
| 127 | CHEK2 | 0.42948651 |
| 128 | ABL1 | 0.42852021 |
| 129 | MAPKAPK3 | 0.42505604 |
| 130 | LIMK1 | 0.41804231 |
| 131 | RPS6KL1 | 0.41621367 |
| 132 | RPS6KC1 | 0.41621367 |
| 133 | CDK14 | 0.40854022 |
| 134 | TAF1 | 0.40637070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.89769111 |
| 2 | Legionellosis_Homo sapiens_hsa05134 | 2.26632116 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.23622633 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.20748453 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 2.05068929 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.93250109 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 1.88016359 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.85867356 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.80519924 |
| 10 | DNA replication_Homo sapiens_hsa03030 | 1.77246710 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 1.71918885 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 1.70414767 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.62852878 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.53838531 |
| 15 | Shigellosis_Homo sapiens_hsa05131 | 1.52063874 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.50089282 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.47897418 |
| 18 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.46339205 |
| 19 | Apoptosis_Homo sapiens_hsa04210 | 1.44984548 |
| 20 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.43666206 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.43408073 |
| 22 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.41021081 |
| 23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.38123763 |
| 24 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.37654305 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.35859780 |
| 26 | Salmonella infection_Homo sapiens_hsa05132 | 1.34882117 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.33486883 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.33438809 |
| 29 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.32592435 |
| 30 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.31597144 |
| 31 | Measles_Homo sapiens_hsa05162 | 1.27496669 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.23760657 |
| 33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.22447403 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.22029421 |
| 35 | Asthma_Homo sapiens_hsa05310 | 1.20280567 |
| 36 | * Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.19644362 |
| 37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.19195528 |
| 38 | Sulfur relay system_Homo sapiens_hsa04122 | 1.18581945 |
| 39 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.17885362 |
| 40 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.16264148 |
| 41 | Proteasome_Homo sapiens_hsa03050 | 1.15145095 |
| 42 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.14252687 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.14215019 |
| 44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.11045149 |
| 45 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.10285245 |
| 46 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.09748581 |
| 47 | Galactose metabolism_Homo sapiens_hsa00052 | 1.08794986 |
| 48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.06961991 |
| 49 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06463761 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 1.00537026 |
| 51 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.96934731 |
| 52 | Mismatch repair_Homo sapiens_hsa03430 | 0.96179312 |
| 53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95306869 |
| 54 | Base excision repair_Homo sapiens_hsa03410 | 0.94948593 |
| 55 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.94508855 |
| 56 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.92881052 |
| 57 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.92559455 |
| 58 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.90947501 |
| 59 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.90799458 |
| 60 | Viral myocarditis_Homo sapiens_hsa05416 | 0.90219487 |
| 61 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.88678933 |
| 62 | Amoebiasis_Homo sapiens_hsa05146 | 0.87137821 |
| 63 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.86858948 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.86800492 |
| 65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86234342 |
| 66 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.86019965 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.84924041 |
| 68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.83840835 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 0.82495541 |
| 70 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.82308586 |
| 71 | Bladder cancer_Homo sapiens_hsa05219 | 0.81634867 |
| 72 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.80333841 |
| 73 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.79886854 |
| 74 | Cell cycle_Homo sapiens_hsa04110 | 0.78490426 |
| 75 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.77535153 |
| 76 | Prion diseases_Homo sapiens_hsa05020 | 0.77298196 |
| 77 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.76443651 |
| 78 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.75273393 |
| 79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75268116 |
| 80 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.74811153 |
| 81 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.74182874 |
| 82 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.73087823 |
| 83 | RNA transport_Homo sapiens_hsa03013 | 0.70865069 |
| 84 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.70802188 |
| 85 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70690700 |
| 86 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.70609301 |
| 87 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.66977430 |
| 88 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.65886396 |
| 89 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.65821856 |
| 90 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.64654105 |
| 91 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64047676 |
| 92 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62826332 |
| 93 | Homologous recombination_Homo sapiens_hsa03440 | 0.60995436 |
| 94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59852080 |
| 95 | Colorectal cancer_Homo sapiens_hsa05210 | 0.59733499 |
| 96 | * Glutathione metabolism_Homo sapiens_hsa00480 | 0.59709035 |
| 97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57573805 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56906283 |
| 99 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.55322181 |
| 100 | * Carbon metabolism_Homo sapiens_hsa01200 | 0.55108986 |
| 101 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.54338495 |
| 102 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54075236 |
| 103 | Spliceosome_Homo sapiens_hsa03040 | 0.53738557 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52883512 |
| 105 | HTLV-I infection_Homo sapiens_hsa05166 | 0.52788908 |
| 106 | Adherens junction_Homo sapiens_hsa04520 | 0.51546867 |
| 107 | Mineral absorption_Homo sapiens_hsa04978 | 0.51500458 |
| 108 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51323579 |
| 109 | Ribosome_Homo sapiens_hsa03010 | 0.51010184 |
| 110 | Endocytosis_Homo sapiens_hsa04144 | 0.50588406 |
| 111 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49415142 |
| 112 | Platelet activation_Homo sapiens_hsa04611 | 0.49352716 |
| 113 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.48291661 |
| 114 | Allograft rejection_Homo sapiens_hsa05330 | 0.47470816 |
| 115 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47240129 |
| 116 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.47079313 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46912191 |
| 118 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.46770224 |
| 119 | Thyroid cancer_Homo sapiens_hsa05216 | 0.46253816 |
| 120 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.46131934 |
| 121 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44455138 |
| 122 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.42518901 |
| 123 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.42069583 |
| 124 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.41339511 |
| 125 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.39219120 |
| 126 | Prostate cancer_Homo sapiens_hsa05215 | 0.36825963 |

